These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37471613)

  • 1. The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer.
    Regan SN; Mierzwa ML
    Cancer J; 2023 Jul-Aug 01; 29(4):226-229. PubMed ID: 37471613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Tumor DNA in Human Papillomavirus-Mediated Oropharynx Cancer: Leveraging Early Data to Inform Future Directions.
    Heft Neal ME; Walline HM; Haring CT
    Cancer J; 2023 Jul-Aug 01; 29(4):215-219. PubMed ID: 37471611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma.
    Haring CT; Dermody SM; Yalamanchi P; Kang SY; Old MO; Chad Brenner J; Spector ME; Rocco JW
    Oral Oncol; 2022 Mar; 126():105776. PubMed ID: 35183912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Uncertainties of Circulating Tumor DNA in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma in the Absence of National Comprehensive Cancer Network Guidelines.
    Xie DX; Kut C; Quon H; Seiwert TY; D'Souza G; Fakhry C
    J Clin Oncol; 2023 May; 41(14):2483-2487. PubMed ID: 36493337
    [No Abstract]   [Full Text] [Related]  

  • 5. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.
    Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV
    Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early HPV ctDNA Kinetics and Imaging Biomarkers Predict Therapeutic Response in p16+ Oropharyngeal Squamous Cell Carcinoma.
    Cao Y; Haring CT; Brummel C; Bhambhani C; Aryal M; Lee C; Heft Neal M; Bhangale A; Gu W; Casper K; Malloy K; Sun Y; Shuman A; Prince ME; Spector ME; Chinn S; Shah J; Schonewolf C; McHugh JB; Mills RE; Tewari M; Worden FP; Swiecicki PL; Mierzwa M; Brenner JC
    Clin Cancer Res; 2022 Jan; 28(2):350-359. PubMed ID: 34702772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
    Zarrabi KK; Galloway TJ; Flieder DB; Kumar SS; Judd J; Bauman JR
    Head Neck; 2022 Aug; 44(8):E25-E30. PubMed ID: 35546490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of plasma circulating tumor DNA for early detection of oligometastatic disease in HPV positive oropharyngeal squamous cell carcinoma.
    Zhang L; Freeman T; Sun S; Bhateja P; Cloyd JM; Rocco JW; Haring CT
    Oral Oncol; 2023 Apr; 139():106357. PubMed ID: 36905900
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.
    Zeng PYF; Cecchini MJ; Barrett JW; Shammas-Toma M; De Cecco L; Serafini MS; Cavalieri S; Licitra L; Hoebers F; Brakenhoff RH; Leemans CR; Scheckenbach K; Poli T; Wang X; Liu X; Laxague F; Prisman E; Poh C; Bose P; Dort JC; Shaikh MH; Ryan SEB; Dawson A; Khan MI; Howlett CJ; Stecho W; Plantinga P; Daniela da Silva S; Hier M; Khan H; MacNeil D; Mendez A; Yoo J; Fung K; Lang P; Winquist E; Palma DA; Ziai H; Amelio AL; Li SS; Boutros PC; Mymryk JS; Nichols AC
    EBioMedicine; 2022 Dec; 86():104373. PubMed ID: 36442320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor HPV DNA for Surveillance of HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Narrative Review.
    Lang Kuhs KA; Brenner JC; Holsinger FC; Rettig EM
    JAMA Oncol; 2023 Dec; 9(12):1716-1724. PubMed ID: 37824111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints.
    Karimi A; Jafari-Koshki T; Zehtabi M; Kargar F; Gheit T
    Cancer Med; 2023 Sep; 12(17):17592-17602. PubMed ID: 37492996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?
    Silver JA; Turkdogan S; Roy CF; Subramaniam T; Henry M; Sadeghi N
    Curr Oncol; 2022 May; 29(5):3668-3697. PubMed ID: 35621685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
    Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in HPV-Related Oropharyngeal Cancers.
    Roof L; Yilmaz E
    Curr Treat Options Oncol; 2023 Mar; 24(3):170-183. PubMed ID: 36719604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma.
    Berger BM; Hanna GJ; Posner MR; Genden EM; Lautersztain J; Naber SP; Del Vecchio Fitz C; Kuperwasser C
    Clin Cancer Res; 2022 Oct; 28(19):4292-4301. PubMed ID: 35576437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papilomaviru-related oropharyngeal squamous cell carcinoma and radiomics: A new era?
    Caprini E; D'Agnese G; Brennan PA; Rahimi S
    J Oral Pathol Med; 2023 Apr; 52(4):300-304. PubMed ID: 36847112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De-Escalation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer: Questions for Practical Consideration.
    Chen AM
    Oncology (Williston Park); 2023 Jul; 37(7):281-287. PubMed ID: 37499250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
    J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.